12 March 2021 News release Geneva The World Health Organization (WHO) listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson), for emergency use in all countries and for COVAX roll-out. The …
COVID-19 Vaccine FAQs
- Outbreak NewsGlobal Health NewsPublic Health News
No-fault compensation programme for COVID-19 vaccines is a world first
The World Health Organization (WHO) and Chubb Limited (NYSE: CB), through ESIS Inc., a Chubb company, signed an agreement on behalf of the COVAX Facility on 17 February 2021 for …
Declaration We must accelerate vaccine equity for all health workers – now Health and care workers have been at the forefront of the pandemic response: often under protected and over …
- Outbreak NewsGlobal Health NewsPublic Health News
WHO lists two additional COVID-19 vaccines for emergency use and COVAX roll-out
AstraZeneca/Oxford-developed vaccines to reach countries in the coming weeks 15 February 2021 The World Health Organization (WHO) listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving the …
- Outbreak NewsActivitiesNoticePublic Health EventsPublic Health Programs
COVID-19 Vaccine FAQs (Nepali)
The Ministry of Health & Population has released Frequently Asked Questions (FAQs) on the COVID-19 vaccine. The COVID-19 vaccination campaign will be launched from Jan 27, 2021 in Nepal.